Cargando…
Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients
The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985531/ https://www.ncbi.nlm.nih.gov/pubmed/33767730 http://dx.doi.org/10.3389/fgene.2021.626642 |
_version_ | 1783668267139727360 |
---|---|
author | Biswas, Nupur Kumar, Krishna Mallick, Priyanka Das, Subhrangshu Kamal, Izaz Monir Bose, Sarpita Choudhury, Anindita Chakrabarti, Saikat |
author_facet | Biswas, Nupur Kumar, Krishna Mallick, Priyanka Das, Subhrangshu Kamal, Izaz Monir Bose, Sarpita Choudhury, Anindita Chakrabarti, Saikat |
author_sort | Biswas, Nupur |
collection | PubMed |
description | The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-19) pandemic has also affected India, infecting more than 10 million till 31st December 2020 and resulting in more than a hundred thousand deaths. In the absence of an effective vaccine, it is imperative to understand the phenotypic outcome of the genetic variants and subsequently the mode of action of its proteins with respect to human proteins and other bio-molecules. Availability of a large number of genomic and mutational data extracted from the nCoV2 virus infecting Indian patients in a public repository provided an opportunity to understand and analyze the specific variations of the virus in India and their impact in broader perspectives. Non-structural proteins (NSPs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus play a major role in its survival as well as virulence power. Here, we provide a detailed overview of the SARS-CoV2 NSPs including primary and secondary structural information, mutational frequency of the Indian and Wuhan variants, phylogenetic profiles, three-dimensional (3D) structural perspectives using homology modeling and molecular dynamics analyses for wild-type and selected variants, host-interactome analysis and viral–host protein complexes, and in silico drug screening with known antivirals and other drugs against the SARS-CoV2 NSPs isolated from the variants found within Indian patients across various regions of the country. All this information is categorized in the form of a database named, Database of NSPs of India specific Novel Coronavirus (DbNSP InC), which is freely available at http://www.hpppi.iicb.res.in/covid19/index.php. |
format | Online Article Text |
id | pubmed-7985531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79855312021-03-24 Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients Biswas, Nupur Kumar, Krishna Mallick, Priyanka Das, Subhrangshu Kamal, Izaz Monir Bose, Sarpita Choudhury, Anindita Chakrabarti, Saikat Front Genet Genetics The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-19) pandemic has also affected India, infecting more than 10 million till 31st December 2020 and resulting in more than a hundred thousand deaths. In the absence of an effective vaccine, it is imperative to understand the phenotypic outcome of the genetic variants and subsequently the mode of action of its proteins with respect to human proteins and other bio-molecules. Availability of a large number of genomic and mutational data extracted from the nCoV2 virus infecting Indian patients in a public repository provided an opportunity to understand and analyze the specific variations of the virus in India and their impact in broader perspectives. Non-structural proteins (NSPs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus play a major role in its survival as well as virulence power. Here, we provide a detailed overview of the SARS-CoV2 NSPs including primary and secondary structural information, mutational frequency of the Indian and Wuhan variants, phylogenetic profiles, three-dimensional (3D) structural perspectives using homology modeling and molecular dynamics analyses for wild-type and selected variants, host-interactome analysis and viral–host protein complexes, and in silico drug screening with known antivirals and other drugs against the SARS-CoV2 NSPs isolated from the variants found within Indian patients across various regions of the country. All this information is categorized in the form of a database named, Database of NSPs of India specific Novel Coronavirus (DbNSP InC), which is freely available at http://www.hpppi.iicb.res.in/covid19/index.php. Frontiers Media S.A. 2021-03-09 /pmc/articles/PMC7985531/ /pubmed/33767730 http://dx.doi.org/10.3389/fgene.2021.626642 Text en Copyright © 2021 Biswas, Kumar, Mallick, Das, Kamal, Bose, Choudhury and Chakrabarti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Biswas, Nupur Kumar, Krishna Mallick, Priyanka Das, Subhrangshu Kamal, Izaz Monir Bose, Sarpita Choudhury, Anindita Chakrabarti, Saikat Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients |
title | Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients |
title_full | Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients |
title_fullStr | Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients |
title_full_unstemmed | Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients |
title_short | Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients |
title_sort | structural and drug screening analysis of the non-structural proteins of severe acute respiratory syndrome coronavirus 2 virus extracted from indian coronavirus disease 2019 patients |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985531/ https://www.ncbi.nlm.nih.gov/pubmed/33767730 http://dx.doi.org/10.3389/fgene.2021.626642 |
work_keys_str_mv | AT biswasnupur structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT kumarkrishna structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT mallickpriyanka structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT dassubhrangshu structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT kamalizazmonir structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT bosesarpita structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT choudhuryanindita structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients AT chakrabartisaikat structuralanddrugscreeninganalysisofthenonstructuralproteinsofsevereacuterespiratorysyndromecoronavirus2virusextractedfromindiancoronavirusdisease2019patients |